leapcure image ad
See all leapcure ads →
Sep 28, 2026
If your lymphoma has progressed after previous treatment, this study could be a new path forward. Researchers in the UK are e...

research.leapcure.com
Living with relapsed AITL or similar T-cell lymphomas? You may qualify for a clinical trial focused on new approaches to treatment.
If your nodal T-cell lymphoma has relapsed or stopped responding to treatment, you may still have options. A clinical trial is studying an investigational oral therapy for adults with AITL, follicular T-cell lymphoma, and other TFH-type lymphomas.
Reach
123.8K
Est. spend
$1.9K
Ran for
11d
Format
dco
Platforms
A world of creative inspiration
Your next great ad
starts with an idea.
Explore 13.5M+ ads in Admanage. Find fresh angles, follow the brands that inspire you, and save your next campaign’s starting point.
Join AdmanageDiscover new ideasBuild your swipe fileExplore brands you love



